Last $0.02 USD
Change Today -0.0019 / -8.64%
Volume 2.0K
ASNB On Other Exchanges
Symbol
Exchange
OTC US
As of 5:10 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

advansource biomaterials cor (ASNB) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
05/15/14 - $0.09
52 Week Low
12/24/14 - $0.02
Market Cap
432.0K
Average Volume 10 Days
69.7K
EPS TTM
$-0.02
Shares Outstanding
21.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ADVANSOURCE BIOMATERIALS COR (ASNB)

Related News

No related news articles were found.

advansource biomaterials cor (ASNB) Related Businessweek News

No Related Businessweek News Found

advansource biomaterials cor (ASNB) Details

AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. The company also manufactures hydrophilic polyurethanes. It sells its products directly to the customers in the United States. The company was formerly known as CardioTech International, Inc. and changed its name to AdvanSource Biomaterials Corporation in October 2008. AdvanSource Biomaterials Corporation was founded in 1993 and is headquartered in Wilmington, Massachusetts.

12 Employees
Last Reported Date: 07/29/14
Founded in 1993

advansource biomaterials cor (ASNB) Top Compensated Officers

Chief Executive officer, President, Treasurer...
Total Annual Compensation: $315.0K
Compensation as of Fiscal Year 2014.

advansource biomaterials cor (ASNB) Key Developments

Advansource Biomaterials Corporation Announces Resignation of David Volpe as Chief Financial Officer

On December 8, 2014, Mr. David Volpe resigned as the Chief Financial Officer of AdvanSource Biomaterials Corporation for personal reasons effective immediately.

AdvanSource Biomaterials Corporation announced delayed annual 10-K filing

On 06/30/2014, AdvanSource Biomaterials Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.

AdvanSource Biomaterials Completes $100,000 Short-Term Financing with Shareholders and Management

AdvanSource Biomaterials Corporation announced the closing of a short-term debt financing transaction on August 22, 2013. The Company entered into Promissory Notes in the aggregate principal amount of $100,000 with three long-standing shareholders and the Company's chief executive officer and chief financial officer. The Notes have a six-month term and bear interest at the rate of 1.75% per month. In lieu of cash payment of interest, the Investors chose to receive Warrants exercisable into an aggregate 435,000 shares of the Company's common stock. The Warrants have a one-year term and are exercisable at a 150% premium over the closing price of the Company's common stock as of August 21, 2013, or $0.075 per share. The Notes are secured by accounts receivable from undisclosed customers. Other than legal fees of approximately $5,000, the Company paid no other transaction costs.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASNB:US $0.02 USD -0.0019

ASNB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ASNB.
View Industry Companies
 

Industry Analysis

ASNB

Industry Average

Valuation ASNB Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVANSOURCE BIOMATERIALS COR, please visit www.advbiomaterials.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.